ZoneOne Pharma Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $994K

  • Investors
  • 2

ZoneOne Pharma General Information

Description

Developer of nano-scale therapeutics based in San Francisco, California. The company develops liposomal chelator therapeutics with contract formulation of liposome drugs and matches drugs with chemistry and biology in order to develop therapies that meet the clinical needs, enabling physicians to accelerate the preclinical development for therapeutic cures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Healthcare Services
Primary Office
  • 1700 4th Street
  • Suite 219
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZoneOne Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-May-2015 $994K Completed Startup
1. Accelerator/Incubator Completed Startup
To view ZoneOne Pharma’s complete valuation and funding history, request access »

ZoneOne Pharma Patents

ZoneOne Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170231910-A1 Pharmaceutical formulations of chelating agents as a metal removal treatment system Inactive 13-Aug-2014 0000000000
US-20170239182-A1 Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systems Inactive 13-Aug-2014 000000000 0
AU-2015301234-A1 Remote loading of sparingly water-soluble drugs into lipid vesicles Inactive 04-Aug-2014 00000000000
CA-2962709-A1 Remote loading of sparingly water-soluble drugs into lipid vesicles Pending 04-Aug-2014 00000000000
EP-3177269-A4 Remote loading of sparingly water-soluble drugs into lipid vesicles Inactive 04-Aug-2014 A61K31/7048 0
To view ZoneOne Pharma’s complete patent history, request access »

ZoneOne Pharma Executive Team (4)

Name Title Board Seat Contact Info
Charles Noble Ph.D Co-Founder & President
Francis Szoka Ph.D Co-Founder & Chairman
Peter Working Ph.D Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

ZoneOne Pharma Board Members (3)

Name Representing Role Since
Francis Szoka Ph.D ZoneOne Pharma Co-Founder & Chairman 000 0000
Michael Motion Ph.D Self Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

ZoneOne Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view ZoneOne Pharma’s complete investors history, request access »